The FDA has approved Seattle Genetics' breast cancer drug Tukysa (tucatinib) four months early, including in certain patients whose disease has spread to the brain. Tukysa has been approved in ...
Figure 1: Uterine histology in aged female wild–type and Bax –/– mice. Figure 3: Ovarian histology of aged Bax –/– female mice following superovulation. Figure 4: Non–atretic follicle numbers in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results